InsiderTrades

Form 4 for TMP TOMPKINS FINANCIAL CORP

Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-15 · accession 0001127602-22-025891 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-17 2022-11-15 TMP BOYCE DAVID S EVP, Pres, CEO Tompkins Ins M - OptEx $53.31 +1,238 24.8K +5% +$66.0K
DM 2022-11-17 2022-11-15 TMP BOYCE DAVID S EVP, Pres, CEO Tompkins Ins F - Tax $84.49 -1,007 24.1K -4% -$85.1K
DM 2022-11-17 2022-11-15 TMP BOYCE DAVID S EVP, Pres, CEO Tompkins Ins M - OptEx $0.00 -1,238 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-15 M A 522 $49.22 24,534 D — —
2 Common Common Stock 2022-11-15 F D 595 $84.49 24,243 D — — (F1) Shares withheld for option cost and taxes.
3 Common Common Stock 2022-11-15 M A 716 $56.29 24,838 D — —
4 Common Common Stock 2022-11-15 F D 412 $84.49 24,122 D — — (F1) Shares withheld for option cost and taxes.
5 Derivative Stock Appreciation Rights (SAR) 2022-11-15 M D 716 $0.00 0 D $56.29 · — to 2025-11-04 716 Common Stock (F2) Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.
6 Derivative Stock Appreciation Rights (SAR) 2022-11-15 M D 522 $0.00 0 D $49.22 · — to 2024-11-21 522 Common Stock (F2) Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.